JGC
STJ

J. Goldman & Co’s St Jude Medical STJ Stock Holding History

J. Goldman & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-95,600
Closed -$7.46M – 474
2016
Q2 		$7.46M Buy
+95,600
New +$6.82M 0.39% 58
2014
Q4 		– Sell
-111,000
Closed -$6.67M – 330
2014
Q3 		$6.67M Buy
+111,000
New +$7.25M 0.4% 75

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

J. Goldman & Co's STJ Position: Q3 2016 in Review

J. Goldman & Co sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 95,600 shares — an estimated $7.46M sold.

J. Goldman & Co first reported a position in STJ in Q3 2014 and held it in 2 quarters. The position peaked at $7.46M in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • J. Goldman & Co reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • J. Goldman & Co sold 95,600 St Jude Medical shares in Q3 2016, an estimated $7.46M.
  • J. Goldman & Co first reported a position in St Jude Medical in Q3 2014 and held it in 2 quarters.
  • J. Goldman & Co's St Jude Medical position peaked at $7.46M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on J. Goldman & Co's 13F filing for Q3 2016, filed 14 Nov 2016.